IN2014MU00367A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00367A
IN2014MU00367A IN367MU2014A IN2014MU00367A IN 2014MU00367 A IN2014MU00367 A IN 2014MU00367A IN 367MU2014 A IN367MU2014 A IN 367MU2014A IN 2014MU00367 A IN2014MU00367 A IN 2014MU00367A
Authority
IN
India
Prior art keywords
cell line
relates
present
against human
human cancer
Prior art date
Application number
Inventor
M V Ramana Dr M
Madhu Radheyshyam Sharma
Original Assignee
M V Ramana Dr M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M V Ramana Dr M filed Critical M V Ramana Dr M
Priority to IN367MU2014 priority Critical patent/IN2014MU00367A/en
Publication of IN2014MU00367A publication Critical patent/IN2014MU00367A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to the Antileukemic activity of N-arylated amino derivatives against human cancer K-562 cell line.
IN367MU2014 2014-02-03 2014-02-03 IN2014MU00367A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN367MU2014 IN2014MU00367A (en) 2014-02-03 2014-02-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN367MU2014 IN2014MU00367A (en) 2014-02-03 2014-02-03

Publications (1)

Publication Number Publication Date
IN2014MU00367A true IN2014MU00367A (en) 2015-09-25

Family

ID=54393746

Family Applications (1)

Application Number Title Priority Date Filing Date
IN367MU2014 IN2014MU00367A (en) 2014-02-03 2014-02-03

Country Status (1)

Country Link
IN (1) IN2014MU00367A (en)

Similar Documents

Publication Publication Date Title
CY1122227T1 (en) ADJUSTMENT OF SUPPLEMENT ACTIVITY
PH12016501763A1 (en) Multispecific antibodies
MX2020003702A (en) Cyclopropylamines as lsd1 inhibitors.
TWD184926S (en) Headgear
MY181069A (en) Methods and processes for non-invasive assessment of genetic variations
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
NZ724691A (en) Quinoline derivatives as smo inhibitors
MX2017008444A (en) Picolinamides as fungicides.
TWD171711S (en) terminal
MX2016009590A (en) Apilimod compositions and methods for using same.
IN2015DE00625A (en)
MY165760A (en) Absorbent article
SG10201900598TA (en) Factor viii formulation
AU2016361427A8 (en) Platinum anticancer agents
MX2018005987A (en) Heterocyclic compounds for the treatment of disease.
PH12017500602A1 (en) Methods for treating ocular conditions
MX2015013021A (en) 5-bromo-indirubins.
IN2014CH00151A (en)
MY187959A (en) Reactor
MY167350A (en) Fat-and-oil composition and chocolate
NZ783086A (en) Concentrated gibberellin solution formulations
IN2014MU00367A (en)
EA201691620A1 (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS
MX2017005669A (en) Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof.
MY168269A (en) Power supply system